Research graph
References from Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2. Local targets link to admitted publications; unresolved targets remain external evidence.
Coronavirus disease 2019 (COVID-19) and cardiovascular disease: A viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection
2020 · External reference
Role of a buried acid group in the mechanism of action of chymotrypsin
10.1038/221337a0 · 1969 · External reference
Rational design, efficient syntheses and biological evaluation of N, N ′-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers
10.1016/j.ejmech.2012.12.044 · 2013 · External reference
10.1007/bf01116558
10.1007/bf01116558 · External reference
10.1016/s0006-291x(89)80157-3
10.1016/s0006-291x(89)80157-3 · External reference
10.1101/2021.03.27.437352
10.1101/2021.03.27.437352 · External reference
Predicting the reactivity of nitrile-carrying compounds with cysteine: A combined computational and experimental study
10.1021/ml400489b · 2014 · External reference
10.3390/ijms22179124
10.3390/ijms22179124 · External reference
Catalytic dyad residues His41 and Cys145 Impact the catalytic activity and overall conformational fold of the main SARS-CoV-2 protease 3-chymotrypsin-like protease
10.3389/fchem.2021.692168 · 2021 · External reference
An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
2021 · External reference
Methods for analyzing and interpreting cooperativity in dose-response curves—II. Partial agonists acting on muscarinic receptors in smooth muscle
10.1016/0306-3623(89)90015-3 · 1989 · External reference
The relationship between homotropic and heterotropic cooperativity for angiotensin receptors in smooth muscle
10.1016/0306-3623(90)90596-e · 1990 · External reference
Design and pharmacology of peptide mimetics
1995 · External reference
Tyrosinate fluorescence lifetimes for oxytocin and vasopressin in receptor-simulating environments: Relationship to biological activity and 1H-NMR data
10.1016/0006-291x(90)90782-i · 1990 · External reference
Pulmonary edema in COVID-19 patients: mechanisms and treatment potential
2021 · External reference
Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial
10.1016/j.eclinm.2021.100962 · 2021 · External reference
Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers
2005 · External reference
Covid-19 infection and mortality: a physiologist’s perspective enlightening clinical features and plausible interventional strategies
10.1152/ajplung.00097.2020 · 2020 · External reference
Reply to Letter to the Editor: “Don’t judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19”
10.1152/ajplung.00133.2020 · 2020 · External reference
10.1136/bmjopen-2020-040644
10.1136/bmjopen-2020-040644 · External reference
Outcomes in patients with COVID-19 infection taking ACEI/ARB
2020 · External reference
Urgent need for evaluating agonists of angiotensin-(1–7)/Mas receptor axis for treating patients with COVID-19
10.1016/j.ijid.2020.05.002 · 2020 · External reference
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
10.1080/22221751.2020.1746200 · 2020 · External reference
10.1073/pnas.2009875117
10.1073/pnas.2009875117 · External reference
ACE2: from protection of liver disease to propagation of COVID-19
10.1042/cs20201268 · 2020 · External reference
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
2020 · External reference
Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19
10.1161/circresaha.120.317134 · 2020 · External reference
10.1056/nejmsr2005760
10.1056/nejmsr2005760 · External reference
Receptor interactions of angiotensin II and angiotensin receptor blockers—relevance to COVID-19
10.3390/biom11070979 · 2021 · External reference
10.1016/j.cell.2018.12.006
10.1016/j.cell.2018.12.006 · External reference
Inhibition of enzymatic degradation of angiotensin II in membrane binding assays: utility of 1,10-phenanthroline
10.1139/o90-028 · 1990 · External reference
10.1038/s41586-020-2180-5
10.1038/s41586-020-2180-5 · External reference
10.1021/acs.jpclett.1c01064
10.1021/acs.jpclett.1c01064 · External reference
10.1016/j.bbamem.2013.03.009
10.1016/j.bbamem.2013.03.009 · External reference
10.3390/microorganisms9071542
10.3390/microorganisms9071542 · External reference
10.1101/2021.08.12.456173
10.1101/2021.08.12.456173 · External reference
10.1126/science.abi7994
10.1126/science.abi7994 · External reference
10.1016/j.yjsbx.2020.100038
10.1016/j.yjsbx.2020.100038 · External reference
10.1038/s41564-021-00908-w
10.1038/s41564-021-00908-w · External reference
1H-NMR studies of [Sar1]angiotensin II conformation by nuclear Overhauser effect spectroscopy in the rotating frame (ROESY): Clustering of the aromatic rings in dimethylsulfoxide
10.1016/0196-9781(90)90093-k · 1990 · External reference
Role of the NH2-terminal domain of angiotensin II (ANG II) and [Sar1]angiotensin II on conformation and activity. NMR evidence for aromatic ring clustering and peptide backbone folding compared with [des-1,2,3]angiotensin II
10.1016/s0021-9258(17)37688-3 · 1994 · External reference
10.1074/jbc.m115.689000
10.1074/jbc.m115.689000 · External reference
Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism
10.1016/j.phrs.2017.06.013 · 2017 · External reference
10.1016/j.cell.2015.04.011
10.1016/j.cell.2015.04.011 · External reference
Electronic sculpting of ligand-GPCR subtype selectivity: the case of angiotensin II
10.1021/cb500063y · 2014 · External reference
New strategies for organic catalysis: the first highly enantioselective organocatalytic Diels−Alder reaction
10.1021/ja000092s · 2000 · External reference
10.1021/ja994280y
10.1021/ja994280y · External reference
The proline-catalyzed direct asymmetric three-component Mannich reaction: scope, optimization, and application to the highly enantioselective synthesis of 1,2-amino alcohols
10.1021/ja0174231 · 2002 · External reference
The crystal structure of l-arginine
10.1039/c2cc17203h · 2012 · External reference
10.1002/jcc.20084
10.1002/jcc.20084 · External reference
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
2009 · External reference
10.1002/jcc.10349
10.1002/jcc.10349 · External reference
Increasing the precision of comparative models with YASARA NOVA-a self-parameterizing force field
10.1002/prot.10104 · 2002 · External reference
Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology
10.1038/s41598-017-09654-8 · 2017 · External reference
10.1093/bioinformatics/btu426
10.1093/bioinformatics/btu426 · External reference
10.1007/978-1-61779-465-0_25
10.1007/978-1-61779-465-0_25 · External reference
Fast empirical pKa prediction by Ewald summation
10.1016/j.jmgm.2006.02.009 · 2006 · External reference
10.1021/acs.jctc.5b00255
10.1021/acs.jctc.5b00255 · External reference
10.1002/jcc.20035
10.1002/jcc.20035 · External reference
10.1002/jcc.10128
10.1002/jcc.10128 · External reference
Comparison of multiple Amber force fields and development of improved protein backbone parameters
10.1002/prot.21123 · 2006 · External reference
10.1063/1.470117
10.1063/1.470117 · External reference
10.1002/jcc.23899
10.1002/jcc.23899 · External reference
10.1073/pnas.2008209117
10.1073/pnas.2008209117 · External reference
10.1021/jp054994x
10.1021/jp054994x · External reference
10.1002/prot.22414
10.1002/prot.22414 · External reference
10.1006/jmbi.1994.1052
10.1006/jmbi.1994.1052 · External reference
PMF scoring revisited
10.1021/jm050038s · 2005 · External reference
Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis
10.1183/13993003.02951-2021 · 2022 · External reference
p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein
10.1002/prp2.798 · 2021 · External reference
